
Liposomal Amphotericin B Injection IP 50mg
10 INR
Product Details:
- Dosage 50 mg
- Usage HIV
- Storage Dry Place
- Appearance Injection
- Click to View more
X
Liposomal Amphotericin B Injection IP 50mg Price And Quantity
- 3000 Box
- 10 INR
Liposomal Amphotericin B Injection IP 50mg Product Specifications
- Injection
- HIV
- Dry Place
- 50 mg
Liposomal Amphotericin B Injection IP 50mg Trade Information
- Telegraphic Transfer (T/T)
- 3000 Box Per Day
- 1 Week
- Yes
- Free samples are available
- South America Western Europe Australia North America Eastern Europe Central America Africa Middle East Asia
- All India
Product Description
Product | Adult dose | Pediatric dose | Adjustment in Renal / Hepatic Impaired patients |
Ambilip | 6mg/kg/day-cryptococcal meningities in HIV. 3-5mg/kg/day in fungal infection | Same as Adults | No |
Product name | Composition | Indication/s | Strengths | Packing |
Ambilip | Liposomal Amphotericin B Inj. | Empirical therapy for presumed fungal infectiomin febrile neutropenic patients, Cryptococcal meningitis in HIV infected patients, infections of Aspergillus species, candida species and/or cryptococcus species infection refractory to amphotericin B deoxycholate, or in patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate, visceral leishmaniasis. | 50mg | 1 Vial |
Product name | Storage | Stability after reconstitution | Prep of solution | Diluent |
Ambilip (Liposomal Amphotericin B 50mg vial) | Lyophilized unopened vial should be stored below 25oC Don not freeze & protect from light. | The reconstituted solution should be used within 24hrs & stable at 2o-8o C. Use with 6 hrs. of dilutions with dextrose 5% do not freeze. | Add 12ml of sterile Water for injection to each 50mg Amblip vial to yield preparation containing the equivalent of 4 mg/ml amphotericin B. Diluted further to yield a final conc.of 1-2mg/ml. | 5% Dextrose |
Other Products in 'Speciality Drugs' category
|
|
![]() |
UNITED BIOTECH (P) LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |